Treatment decisions and employment of breast cancer patients: Results of a population-based survey
- PMID: 28990155
- PMCID: PMC5716845
- DOI: 10.1002/cncr.30959
Treatment decisions and employment of breast cancer patients: Results of a population-based survey
Abstract
Background: Many patients with breast cancer work for pay at the time of their diagnosis, and the treatment plan may threaten their livelihood. Understanding work experiences in a contemporary population-based sample is necessary to inform initiatives to reduce the burden of cancer care.
Methods: Women who were 20 to 79 years old and had been diagnosed with stage 0 to II breast cancer, as reported to the Georgia and Los Angeles Surveillance, Epidemiology, and End Results registries in 2014-2015, were surveyed. Of the 3672 eligible women, 2502 responded (68%); 1006 who reported working before their diagnosis were analyzed. Multivariate models evaluated correlates of missing work for >1 month and stopping work altogether versus missing work for ≤1 month.
Results: In this diverse sample, most patients (62%) underwent lumpectomy; 16% underwent unilateral mastectomy (8% with reconstruction); and 23% underwent bilateral mastectomy (19% with reconstruction). One-third (33%) received chemotherapy. Most (84%) worked full-time before their diagnosis; however, only 50% had paid sick leave, 39% had disability benefits, and 38% had flexible work schedules. Surgical treatment was strongly correlated with missing >1 month of work (odds ratio [OR] for bilateral mastectomy with reconstruction vs lumpectomy, 7.8) and with stopping work altogether (OR for bilateral mastectomy with reconstruction vs lumpectomy, 3.1). Chemotherapy receipt (OR for missing >1 month, 1.3; OR for stopping work altogether, 3.9) and race (OR for missing >1 month for blacks vs whites, 2.0; OR for stopping work altogether for blacks vs whites, 1.7) also correlated. Those with paid sick leave were less likely to stop working (OR, 0.5), as were those with flexible schedules (OR, 0.3).
Conclusions: Working patients who received more aggressive treatments were more likely to experience substantial employment disruptions. Cancer 2017;123:4791-9. © 2017 American Cancer Society.
Keywords: breast cancer; chemotherapy; employment; job; mastectomy; work.
© 2017 American Cancer Society.
Figures


Similar articles
-
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis.Breast Cancer Res Treat. 2010 Jan;119(1):213-20. doi: 10.1007/s10549-009-0389-y. Epub 2009 Apr 10. Breast Cancer Res Treat. 2010. PMID: 19360466 Free PMC article.
-
Treatment experiences of Latinas after diagnosis of breast cancer.Cancer. 2017 Aug 15;123(16):3022-3030. doi: 10.1002/cncr.30702. Epub 2017 Apr 11. Cancer. 2017. PMID: 28398629 Free PMC article.
-
Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.Cancer. 2018 Jul 1;124(13):2714-2723. doi: 10.1002/cncr.31378. Epub 2018 Apr 18. Cancer. 2018. PMID: 29669187 Free PMC article.
-
A Narrative Review of the Confluence of Breast Cancer and Low-wage Employment and Its Impact on Receipt of Guideline-recommended Treatment.Glob Adv Health Med. 2013 Sep;2(5):75-85. doi: 10.7453/gahmj.2013.046. Glob Adv Health Med. 2013. PMID: 24416698 Free PMC article. Review.
-
[Return to work after a cancer diagnosis].Rev Prat. 2019 Apr;69(4):449-453. Rev Prat. 2019. PMID: 31626505 Review. French.
Cited by
-
Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea.Gastric Cancer. 2024 Nov;27(6):1159-1168. doi: 10.1007/s10120-024-01541-2. Epub 2024 Aug 12. Gastric Cancer. 2024. PMID: 39133396
-
Breast Cancer-Related Employment Disruption and Financial Hardship in the Sister Study.JNCI Cancer Spectr. 2021 Mar 17;5(3):pkab024. doi: 10.1093/jncics/pkab024. eCollection 2021 Jun. JNCI Cancer Spectr. 2021. PMID: 34104865 Free PMC article.
-
Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.Oral Oncol. 2020 Feb;101:104521. doi: 10.1016/j.oraloncology.2019.104521. Epub 2019 Dec 23. Oral Oncol. 2020. PMID: 31877502 Free PMC article.
-
The role of physical arm function and demographic disparities in breast cancer survivors' ability to return to work.Support Care Cancer. 2022 Dec;30(12):10301-10310. doi: 10.1007/s00520-022-07449-w. Epub 2022 Nov 10. Support Care Cancer. 2022. PMID: 36355217 Free PMC article. Review.
-
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.JAMA Oncol. 2018 Aug 1;4(8):1066-1072. doi: 10.1001/jamaoncol.2018.0644. JAMA Oncol. 2018. PMID: 29801090 Free PMC article.
References
-
- Spelten ER, Sprangers MA, Verbeek JH. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002;11:124–31. - PubMed
-
- Kennedy F, Haslam C, Munir F, et al. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl) 2007;16:17–25. - PubMed
-
- Bushunow PW, Sun Y, Raubertas RF, et al. Adjuvant chemotherapy does not affect employment in patients with early-stage breast cancer. J Gen Intern Med. 1995;10:73–6. - PubMed
-
- Drolet M, Maunsell E, Brisson J, et al. Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol. 2005;23:8305–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical